Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341977 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution
A NA study of Healthy Contact Lens Wearers, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 573
- Enrollment target
- 1
- Study location
NCT01341977: Completed NA study of Healthy Contact Lens Wearers, sponsored by Alcon Research.
NCT01341977 is a NA study of Healthy Contact Lens Wearers that has completed, run by Alcon Research. The registered enrollment target is 573 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01341977, a NA study of Healthy Contact Lens Wearers, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 573 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if Alcon MPDS is safe and effective for silicone hydrogel and soft hydrogel contact lens wearers.
Primary Outcome
Lens Moisture Subject Rated Likert Item (1-Strongly Agree to 5-Strongly Disagree)
Conditions Studied
Interventions
- DEVICE Alcon MPDS
- DEVICE ReNu Fresh MPS
Study Locations (1)
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 573 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT01341977 record still lists
NCT01341977 is an interventional study that assigns participants to a tested intervention. The registered 573 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Healthy Contact Lens Wearers appearing as the primary indexed condition, and to 2 interventions - of which Alcon MPDS is the first listed.
NCT01341977 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01341977 about?
NCT01341977 is a clinical study titled "Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution". The purpose of this study is to determine if Alcon MPDS is safe and effective for silicone hydrogel and soft hydrogel contact lens wearers.
What is the current status of trial NCT01341977?
This trial is currently completed. It is a NA study. The enrollment target is 573 participants. The study started on 2009-11. Estimated completion is 2010-05.
What conditions does trial NCT01341977 study?
This clinical trial studies the following conditions: Healthy Contact Lens Wearers.
What interventions are being tested in trial NCT01341977?
The interventions under investigation include: Alcon MPDS (DEVICE), ReNu Fresh MPS (DEVICE).
Who is sponsoring clinical trial NCT01341977?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01341977 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01341977's enrollment target sits among peer trials
573 179th of 2000 higher than 1,822 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977751 · 573 participants · NA
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
- NCT07349537 · 574 participants · Phase 1
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia